Concepedia

Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study

Godela Brosnahan, Wei Wang, Berenice Y. Gitomer, Taylor Struemph, Diana George, Zhiying You, Kristen L. Nowak, Jelena Klawitter, Michel B. Chonchol

American Journal of Kidney Diseases · 2021 · 59 citations · 40 references

DOIFull text

Open access

Concepts

References

40

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research · 2017 · 29.7K citations · Full text

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine · 2009 · 25K citations

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.5K citations · Full text

Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease

Qing Yao, Ming Wu, Jie Zhou et al. · Kidney & Blood Pressure Research · 2017 · 846 citations · Full text

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

Jonathan M. Shillingford, Noel Murcia, Claire H. Larson et al. · Proceedings of the National Academy of Sciences · 2006 · 790 citations · Full text

, , +19